Evidence map›Paper›PMID 37283098›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2023

Feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate in day surgery mode.

Zhihui Zou, Ligang Zhang, Keke Cai, Yongtao Hu, Shuchen Liu, Jia Chen, Qintao Ge, Xiaohu Zhao, Zongyao Hao, Chaozhao Liang

Abstract read
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhihui ZouDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Provincial Key Laboratory of Genitourinary Diseases, Anhui Clinical Research Center of Urinary System Diseases, Hefei 230022, China. qvb119@163.com.
Ligang ZhangDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Provincial Key Laboratory of Genitourinary Diseases, Anhui Clinical Research Center of Urinary System Diseases, Hefei 230022, China.
Keke CaiDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Provincial Key Laboratory of Genitourinary Diseases, Anhui Clinical Research Center of Urinary System Diseases, Hefei 230022, China.
Yongtao HuThe First Clinical Medical College, Anhui Medical University, Hefei 230022, China.
Shuchen LiuThe First Clinical Medical College, Anhui Medical University, Hefei 230022, China.
Jia ChenThe First Clinical Medical College, Anhui Medical University, Hefei 230022, China.
Qintao GeThe First Clinical Medical College, Anhui Medical University, Hefei 230022, China.
Xiaohu ZhaoThe First Clinical Medical College, Anhui Medical University, Hefei 230022, China.
Zongyao HaoDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Provincial Key Laboratory of Genitourinary Diseases, Anhui Clinical Research Center of Urinary System Diseases, Hefei 230022, China.
Chaozhao LiangDepartment of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Anhui Provincial Key Laboratory of Genitourinary Diseases, Anhui Clinical Research Center of Urinary System Diseases, Hefei 230022, China. liang_chaozhao@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the feasibility and safety of bipolar-plasmakinetic transurethral enucleation and resection of the prostate (B-TUERP) in day surgery.

methodsFrom January 2021 to August 2022, 34 patients with benign prostatic hyperplasia (BPH) underwent B-TUERP in day surgery in the First Affiliated Hospital of Anhui Medical University. Patients completed the screening and anesthesia evaluation before admission and received the standard surgery which implements "anatomical enucleation of the prostate" and "absolute bleeding control" on the same day of admission, and by the same doctor. Bladder irrigation was stopped, catheter was removed and the discharge evaluation was performed on the first day after operation. The baseline data, perioperative conditions, time of recovery, treatment outcomes, hospitalization costs, and postoperative complications were analyzed.

resultsAll operations were successfully conducted. The average age of the patients was (62.2±7.8) years, average prostate volume was (50.2±29.3) mL. The average operation time was (36.5±19.1) min, the average hemoglobin and blood sodium were decreased by (16.2±7.1) g/L and (2.2±2.0) mmol/L, respectively. The average postoperative length of hospital stay, and total length of hospital stay were (17.7±2.2) and (20.8±2.1) h, respectively, and the average hospitalization cost was (13 558±2320) CNY. All patients were discharged on the day after surgery except for one patient who was transferred to a general ward. Three patients received indwelling catheterization after catheter removal. The 3-month follow-up results showed a substantial improvement in the International Prostate Symptom Score, quality of life score and maximum urinary flow rate (all

conclusionsThe preliminary results showed that B-TUERP ambulatory surgery is a safe, feasible, economical and effective treatment for appropriately selected patients with BPH.

Indexed as

ProstateProstatic HyperplasiaAgedAmbulatory Surgical ProceduresFeasibility StudiesHumansMaleMiddle AgedQuality of LifeRetrospective StudiesTreatment OutcomeBenign prostatic hyperplasiaBipolar-plasmakineticDay surgeryEnucleation of prostateTransurethral surgery

Identifiers

PMID37283098
PMCPMC10288435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.